SII TCV(B)

N/A

Report date: 2026/03/19 20:00:18

Base Information

Drug NameSII TCV(B)
Drug Alias NameSii-PTCVSII-PTCVSII bivalent paratyphoid A-typhoid conjugate vaccine(Serum Institute Of India Pvt Ltd)
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTyphoid FeverParatyphoid Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSerum Institute Of India Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSerum Institute Of India Pvt LtdUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsTyphoid FeverParatyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A